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INTRODUCTION
Few emergencies in neurosurgery are as worrisome as a large acute subdural hematoma
(ASDH) (Fig. 1). Many of these lesions require immediate evacuation, regardless of the time of
day or day of the week. Fortunately for the affected
patients, the vast majority of ASDHs are relatively
small, thus allowing initial management to consist
of nonsurgical observation.
The decision that emergency surgery is not
needed is soon followed by an obvious question:
what will happen to the ASDH? The ideal scenario
is that it will gradually resorb and the patient will
be left with no deficits. But the worst-case scenario
is rapid and unexpected enlargement of the hematoma, causing the patient to undergo neurologic

deterioration and immediate surgical evacuation.
Over a more protracted course, another suboptimal outcome is progression of a small ASDH to a
large chronic subdural hematoma (CSDH) (Figs. 2
and 3), which may enlarge to such an extent that
surgical evacuation becomes necessary (Fig. 4).
Despite the frequency with which neurosurgeons have to make these decisions, and despite
the likely increase in incidence of small but potentially worrisome ASDHs as the population ages,
becomes more prone to falls, and consumes
more antiplatelet and anticoagulant medications,
relatively little work has been reported on the natural history of ASDHs. Most published reports are
based on retrospective reviews of case series or of
large public registries.
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 Although guidelines for surgical decision-making in patients with acute subdural hematomas
(ASDHs) are widely available, the evidence supporting these guidelines is weak, and management
of these patients must often be individualized.
 Smaller ASDHs in patients in good neurologic condition usually can be successfully managed
without surgery.
 Large ASDHs with minimal mass effect in patients with minimal symptoms also may be considered
for nonoperative management.
 The literature is divided about the effects of anticoagulant and antiplatelet medications on rapid
growth of ASDHs and on their likelihood of progression to large chronic subdural hematomas,
but it is reasonable to reverse the effects of these medications promptly.
 Close clinical and radiologic follow-up is needed in these patients, both acutely to detect rapid
expansion of an ASDH, and subacutely to detect formation of a large subacute or chronic subdural
hematoma.
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Fig. 1. Representative CT images of a left convexity ASDH with no underlying skull fracture (axial, coronal, and
sagittal, from left to right, respectively). There is a small amount of left-to-right midline shift with mass effect on
the left lateral ventricle. The basilar cisterns are preserved, without signs of herniation.

DEMOGRAPHICS
Traumatic brain injury (TBI) is a significant cause of
mortality and permanent disability across the
globe. TBI represents a spectrum of disease processes that ranges from concussion to large
intra-axial and extra-axial intracranial hematomas,
including ASDH.
For patients with TBI in general, outcomes have
improved somewhat over the past decades
because of better organization of emergency medical systems, greater speed and quality of
computed tomography (CT) scanning, and refinements in general critical care practices.
However, mortality and outcome in patients
with ASDH have not seen as much improvement.
Mortality has been reported to range from 50%
to 90%1–4 or even higher in some series that
include patients receiving anticoagulant therapies.5 Associated intracranial and extracranial
injuries are common and may contribute to

increased morbidity and mortality.6 Overall outcomes may worsen in coming years as the population ages.

SPECIFIC TYPES OF ACUTE SUBDURAL
HEMATOMA
The natural history of a subdural hematoma (SDH)
is influenced by whether it is traumatic or nontraumatic in origin (Table 1). A retrospective cohort
study based on several statewide administrative
claims databases analyzed more than 27,000 patients with conservatively managed SDH. This
study included both traumatic SDH, identified
by such International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM)
discharge codes as 852.2x or 852.3x, and nontraumatic SDH, coded as 432.1.7 Approximately
71% of all cases were traumatic SDHs, and 29%
were nontraumatic. This latter group had higher
rates of subsequent SDH-related hospitalization,

Fig. 2. Sequential change of CT
density of an ASDH and its proposed
mechanism. (From Lee KS. Natural
history of chronic subdural haematoma. [Review]. Brain Injury 2004;18:
354; with permission.)
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Fig. 3. Schematic representation of
the origin and pathogenesis of SDHs
and the relationship among the 3
traumatic subdural lesions. SDG,
subdural hygroma. (From Lee KS.
Natural history of chronic subdural
haematoma. [Review]. Brain Injury
2004;18:356; with permission.)

surgery, and death. The overall readmission rate
within 90 days for SDH was approximately 1 in 8.

Parafalcine and Tentorial Acute Subdural
Hematoma
Certain subtypes of traumatic ASDH and certain
patient characteristics taken together may
portend a benign course. Howard and colleagues8 found that isolated thin parafalcine and
tentorial ASDHs in younger patients with mild
TBI (Glasgow Coma Scale [GCS] score 13–15)
did not enlarge, even when patients were taking
antiplatelet or anticoagulant agents, or both.
They suggested that such patients could be
managed on a standard medical/surgical ward
and did not require observation in an intensive
care unit or intermediate care unit. However,
only 65 patients met inclusion criteria for their
study, which represented 8% of all patients
admitted to their Level I trauma center with an
ICD-9 code for SDH after closed head injury.

Posterior Fossa Acute Subdural Hematoma
Although rare, traumatic posterior fossa ASDHs are
often associated with poor outcome. In a retrospective analysis of their experience with 10 patients, Takeuchi and colleagues9 reported a 90%
poor outcome rate and a 50% mortality rate in patients with posterior fossa ASDH. Half of their patients exhibited coagulopathy. Their review of the
literature revealed that posterior fossa SDHs were
associated with occipital impacts and fractures,
low GCS score, additional intracranial lesions
(especially supratentorial lesions and intracerebellar hematomas), a significant rate of lesion evolution within the first 2 postinjury days, and high
rates of poor outcome and mortality. Similarly, Oliveira de Amorim and colleagues10 retrospectively
identified 4 cases of traumatic posterior fossa
ASDH from their own institution and added an additional 57 cases from the literature. More than half
the patients had an initial GCS score below 8, and
unfavorable outcomes were recorded in 63%.
Fig. 4. The left axial CT image illustrates a CSDH. The image on the
right depicts the original ASDH (arrows) from which the chronic hematoma originated.
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Table 1
Etiologies of acute subdural hematomas
Type

Causes

Trauma

Motor vehicle collisions,
falls, assaults, accidents
Coagulopathy
Warfarin, heparin,
or medical
hemophilia, liver disease,
anticoagulation
thrombocytopenia
Nontraumatic
Cerebral aneurysm,
hemorrhage
arteriovenous
malformation, tumor
(especially meningioma
or dural metastasis)
Postsurgical
Craniotomy, CSF shunting
Intracranial
Lumbar puncture,
hypotension
lumbar CSF leak,
lumboperitoneal shunt,
spinal epidural
anesthesia
Inflicted injury
Usually pediatric age
group; also can be seen
in the elderly
Spontaneous or
Rare
unknown
Abbreviation: CSF, cerebrospinal fluid.

Nontraumatic Acute Subdural Hematoma
Numerous nontraumatic conditions may cause
ASDH, either as a result of direct bleeding into
the subdural space or as an extension of an intraparenchymal hematoma into the subdural space.
These conditions include (1) ruptured intracranial
aneurysm, (2) ruptured cortical artery, (3) hypertensive cerebral hemorrhage, (4) neoplasm, (5)
hematologic disorder, (6) anticoagulant or thrombolytic therapy, (7) cerebral amyloid angiopathy,
(8) dural arteriovenous fistula, and (9) acquired immune deficiency syndrome (Table 2).11

INITIAL DECISION-MAKING
The decision about whether to pursue nonoperative management of a patient with ASDH or to proceed with surgery is guided by the clinical
examination and by imaging findings. The bedside
examination can be repeated as often as desired.
However, repeating imaging at frequent intervals
can be unduly burdensome. It also increases
costs and adds to a patient’s cumulative radiation
exposure. Many reports have demonstrated success in not obtaining follow-up CT scans in certain
patients whose neurologic examinations remain
at or near normal. This strategy is especially

well-suited for patients with very small traumatic
hemorrhagic lesions and clinically mild injuries.
Very thin, low-volume SDHs may fall into this
category.
With larger ASDHs, concern about potential
enlargement may prompt follow-up CT scanning
roughly 4 to 6 hours after an initial scan. Significant
expansion of an ASDH may lead to immediate surgery before the patient exhibits associated clinical
findings. Less dramatic growth of the lesion may
lead to plans for another scan several hours later
to determine if the clot has stabilized, or if it has
continued to enlarge and may thus require surgical
evacuation. Deciding to take a patient for surgical
evacuation of an ASDH because of lesion growth
on imaging studies, rather than change in neurologic examination, may occur more commonly in
elderly patients. Age-associated cerebral atrophy
may allow such patients to harbor relatively large
hematomas without initially demonstrating symptoms. But after 1 or 2 days, edema of compressed
brain tissue and of the hematoma itself may lead to
neurologic worsening even if the active bleeding
that created the hematoma has ceased.

Antiplatelet and Anticoagulant Medications
A patient’s use of anticoagulants and/or newer antiplatelet medications would seem to be an
obvious risk factor for enlargement of a small
ASDH. However, some published reports fail to
support this assumption or even provide data to
refute it. The retrospective design of these studies
and of their data collection may partially explain
such findings. Aggressive reversal of these medications should be the neurosurgeon’s standard
approach, modified as necessary by the particular
circumstances of each individual case.
Ivascu and colleagues12 reported that even an
emergency department protocol for prompt physician evaluation of patients known to be taking
anticoagulant medications does not improve outcomes without a concomitant protocol for aggressive therapeutic intervention. The generalizability
of these results may be limited because types of
intracranial hemorrhage other than ASDH also
were included, and more importantly, many anticoagulants other than warfarin are now in widespread use. Reversal of these other agents is
very difficult or even not possible in some cases.
But the underlying message that speedy treatment
is essential is one that should be remembered by
emergency physicians and others who see these
patients soon after trauma.
The influence of anticoagulant or antiplatelet
medications in the transformation of a small
ASDH into a CSDH that is large enough to require
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Table 2
Nontraumatic causes of acute subdural hematomas
Type

Epidemiology

Brief Discussion

Ruptured intracranial
aneurysm

2%–10% of ruptured aneurysms
result in SDH. Typically women.

Ruptured cortical artery

Spontaneous rupture occurs
predominantly in men.
Accounts for 80% of reported
cases.

Hypertensive intracerebral
hemorrhage

Reported to occur in 6% of
hypertensive hemorrhages and
most often involves cerebellar
hematomas.

Neoplasm

Most common malignancies
associated with SDH are
leukemia and metastatic
carcinoma.

Hematological disorder

Typical age of the individual
is <18 y, but may also occur in
neonates and infants.

Other conditions

—

In most cases there is an
associated subarachnoid
hemorrhage. The location of
the responsible aneurysm is
most often the internal carotid
artery or the anterior
communicating artery.
The location in all cases reported
is typically a vessel at or near
the Sylvian fissure, originating
from branches of the middle
cerebral artery. The anatomic
arrangement that predisposes
to spontaneous rupture
includes a fragile right-angled
artery or an artery “bridging”
the subdural space.
SDH may result from extension of
an intracerebral hypertensive
hemorrhage rupturing through
the cerebral cortex to involve
the subdural space.
Hypertension may also result in
SDH by causing rupture of a
cortical artery.
A variety of neoplasms are
associated with SDH. These
include primary tumors of the
brain and its coverings,
hematologic malignancies, and
metastatic tumors. In some
cases, SDH may be the first
symptoms of the tumor.
In most cases of disorders of the
hematopoietic system, factor
deficiency (inherited or
acquired) is the most common
type. Individuals with Factor VIII
and IX deficiency have factor
activity levels of 0–1 U/dL. Fatal
nontraumatic SDH has been
reported in an individual with
lupus anticoagulant.
Nontraumatic SDH has been
described in conditions that
include therapy with
anticoagulants, thrombolytic
therapy, cerebral amyloid
angiopathy, dural
arteriovenous fistulas, and
acquired immune deficiency
syndrome.

Abbreviation: SDH, subdural hematoma.
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surgical drainage is unclear. It is possible that any
such effect varies both with the specific medication and/or also with the dosage. Laviv and Rappaport13 retrospectively analyzed their experience
with conservative management of patients with
ASDH. They reported that, of 21 patients taking
anticoagulants, antiaggregants, or clopidogrel,
20 (95%) later underwent surgical drainage of a
CSDH. Overall, the group that developed surgically treated CSDHs had thicker initial hematomas
than the nonoperated group.13

NONOPERATIVE MANAGEMENT
Significant medical comorbidities are common in
elderly patients and are often of sufficient severity
to preclude an intervention as aggressive as a
craniotomy. The cerebral atrophy that accompanies normal aging offers some protection from
ASDH by creating extra intracranial volume into
which an acute hematoma can expand, thus
allowing nonoperative management to be successful in many cases.
The greatest risk of nonoperative management
is the potential for neurologic deterioration. This
risk, and the likelihood of subsequent permanent
neurologic impairment, must be considered in
the context of the risks of surgical intervention.
There appears to be little acute risk of other complications of nonoperative management of these
patients. Seizures have not been reported to occur
more commonly in patients with an unevacuated
ASDH. The same is true regarding ischemic injury
to compressed underlying brain tissue.
A related question is the setting in which such
patients should be observed. There are at least 2
factors that must be considered.
 The first is early detection of neurologic deterioration. Because of the need to detect such
an event quickly and then to initiate immediate
action, many patients are better off in an
intensive care unit or similar setting in which
they can be assessed frequently by trained
examiners.
 The other factor is prompt access to neurosurgical intervention. Securing prompt access
does not necessarily require that all such
patients must be physically transferred to a
hospital with around-the-clock access to a
neurosurgical operating room. If foolproof
mechanisms have been created for immediate transfer of worsening patients to a neurosurgical facility, then observation at the
original hospital may be reasonable in many
cases because relatively few such patients
will suffer neurologic deterioration.

Progression to Chronic Subdural Hematoma
After Conservative Management
Occasionally, patients with large ASDHs who
would normally be taken for surgical evacuation
may be too frail or may have such significant underlying comorbidities that subjecting them to
general anesthesia and craniotomy is not a viable
option, even if they display unilateral weakness
or other signs of mass effect. Allowing several
days to pass so that the solid acute hematoma undergoes significant liquefaction as it progresses to
a subacute hematoma may be the best approach
in some of these cases because the liquefied hematoma often can be drained through a bur hole
or other minimally invasive approach under local
anesthesia.
In a retrospectively analyzed series of 177 patients, Lee and colleagues14 compared 16 patients
(9%) in whom nonoperatively managed ASDH progressed to CSDH requiring surgical evacuation
with 161 patients in whom ASDH resolved with
conservative management. These investigators
found that older age and larger hematoma size
were associated with progression of ASDH to
symptomatic CSDH. They also found a slightly
higher hematoma density as measured in Hounsfield units. They did not find a correlation with
use of anticoagulant or antiplatelet agents, but
the numbers of such patients were small, and
abnormal clotting parameters were treated with
blood products, thus obscuring any potential effect of these medications.
In another series of 27 patients with traumatic
ASDH who were managed nonoperatively, 1
(4%) deteriorated and required craniotomy.15
Four patients (15%) demonstrated evolution into
CSDH and underwent bur hole drainage 15 to
21 days after injury. The remaining 22 patients
(81%) required no additional treatment. No patients developed seizures. Mean duration of
follow-up was 6 weeks.

Spontaneous Resolution of Acute Subdural
Hematoma
Case reports stretching back over decades have
documented apparent resolution of ASDHs in patients with obvious neurologic compromise from
the hematomas, including coma, asymmetric motor findings, and unilateral pupillary dilatation.
Concurrent injuries, underlying medical comorbidities, and/or family refusal to consent to surgery
represent reasons why emergency craniotomy
was not performed.
Wen and colleagues16 described their experience with such a patient and identified 19 additional cases in the literature. They reported that
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the following features seem to characterize most
of these cases: (1) coma less than 12 hours in
duration after the initial injury; (2) absence of cerebral contusion; (3) thin width and wide distribution
of the hematoma; (4) presence of a low-density
band between the hematoma and the inner table
of the skull on initial CT scan; and (5) lack of severe
initial TBI, with initial GCS score greater than 8.
Fujimoto and colleagues17 retrospectively
reviewed 56 patients with ASDH with midline
shift of more than 10 mm and clot thickness larger
than 10 mm who did not undergo immediate
surgery, most commonly because of advanced
age, poor general condition, or family wishes, or
because patients did not exhibit significant neurologic symptoms. Rapid spontaneous resolution of
the ASDH was defined as neurologic improvement
within 24 hours and decrease of hematoma thickness by more than 5 mm within 96 hours. Eighteen
patients (32%) demonstrated rapid spontaneous
resolution. Multivariate analysis found that preinjury use of antiplatelet agents and presence of a
low-density band between the hematoma and the
inner wall of the skull on initial CT scan were independent predictive factors for rapid spontaneous
resolution.
Commonly proposed explanations for rapid
decrease in size and mass effect of an ASDH
include a tear in the arachnoid that permits cerebrospinal fluid to wash away the acute blood,
and/or redistribution rather than true resorption
of the acute blood, which may be facilitated by a
decrease in intracranial pressure after treating
physicians’ medical interventions. Interestingly,
however, others have reported that decreasing
brain compliance by adjusting upward the valve
setting of an already-present ventriculoperitoneal
shunt was associated with disappearance of an
ASDH within 6 days.18 Of course, the very fact
that these cases are unusual enough to merit publication demonstrates how rare it is for a sizable
ASDH to resolve rapidly. Immediate surgery is
the recommended treatment for these patients.

OUTCOMES WITH NONOPERATIVE
MANAGEMENT
Acute deterioration has been recognized for decades as a potential outcome of nonoperative
management of patients with acute traumatic
intracranial hemorrhage. The terms “talk and deteriorate” or “talk and die” vividly describe this phenomenon. In 1987, Rockswold and colleagues19
reported on 33 of 215 patients with severe TBI
who exhibited such deterioration. Twenty-five
(76%) of these 33 patients underwent surgery,
and of those 25, 14 had ASDHs. More aggressive

use of early follow-up CT scanning in recent years
seems to have lowered the rate of such events, but
they still occur with sufficient frequency that virtually every neurosurgeon has personal experience
with this type of patient.
In a 1994 review at their Level I trauma center of
ASDH management in 83 patients with GCS score
11 to 15, Croce and colleagues20 found that nonoperatively managed patients had fewer focal
neurologic deficits, smaller hematomas, and less
cisternal effacement. Outcomes did not differ between groups. Of the 58 patients managed nonsurgically, 6% later required surgery for CSDH.
Bullock and colleagues attempted nonoperative
management in 23 conscious patients (3%) of 837
with traumatic ASDH.2 In a retrospective analysis,
they report that 6 (26%) of the 23 later underwent
burr hole drainage of their hematomas at a mean
of 15 days after injury. The ASDHs in the 6 operated
patients were significantly larger than in the other
17 patients. The investigators proposed the
following criteria for attempting nonoperative management of patients with traumatic ASDH: (1) GCS
score greater than or equal to 13; (2) absence of
associated intraparenchymal hematomas, contusions, or edema; (3) midline shift less than 10 mm;
and (4) absence of basal cisternal effacement.
Ellenbogen and colleagues reviewed outcomes
in 1427 patients with ASDH referred to their Level
I trauma center. Such a population would be expected to have an overall greater severity of injury
than that seen at most hospitals. GCS score
exceeded 12 in only 58% of patients. Mean age
was 58 years. A total of 248 (17%) patients underwent surgical evacuation of their SDHs. Mean
length of stay was 9.6 days, and 40% spent 2 or
more days in the intensive care unit. Overall inpatient mortality was 16% and was essentially the
same in operated and nonoperated groups. Medical complications occurred in 28% of the overall
series and most commonly consisted of pneumonia, urinary tract infection, or acute respiratory
distress syndrome. Complications did not differ
between operated and nonoperated patients. At
discharge, 94% of patients had a GCS score of
more than 12. The investigators note that their
mortality rate was lower than that reported in other
studies of traumatic ASDH and that their rates of
deep venous thrombosis and pulmonary embolism were lower than expected. They suggest
that earlier diagnosis of ASDH and improvement
in care from regionalization of emergency medical
systems may explain their findings.21
Kim and colleagues22 described 98 patients
with mild TBI (GCS score 13–15) and ASDH in
whom outcome was assessed by enlargement of
the SDH on subsequent imaging and by the need
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for subsequent surgical evacuation. Roughly twothirds of these patients demonstrated regression
of the SDH. The other 35% underwent delayed
surgical evacuation at a median of 17 days after
injury. Larger hematoma volume and midline shift
were associated with the need for delayed
hematoma evacuation. Interestingly, subarachnoid hemorrhage and cerebral contusions were
more common in the nonoperative group. Reasons for the higher failure rate of conservative
management in this series as compared with those
in other reports are unclear and may relate to a
lower threshold for taking patients to the operating
room for delayed evacuation of an SDH.
Feliciano and colleagues23 reported outcomes
of nonoperated ASDH in a series of 38 patients,
roughly half of whom were younger than 65 years.
In 87% of these patients, midline shift was 5 mm or
less, and hematoma thickness was 10 mm or less.
Six patients in this group were taking antiplatelet
or anticoagulant medications, and some were
treated with blood products. Use of these medications was not associated with outcome in this subgroup with smaller hematomas. None of these
patients required surgery. In the other 5 patients
with hematoma thickness of more than 10 mm
or shift greater than 5 mm, surgery was not
performed because of excessive cardiac risk or
withholding of consent by relatives. One patient
in this group required surgery for neurologic
deterioration.
Bajsarowicz and colleagues24 retrospectively
reviewed 646 patients with traumatic ASDH who
were initially treated conservatively. Forty-two
patients eventually required delayed surgical intervention after a median of 9.5 days, most commonly
for symptomatic enlargement of the hematoma
(median 14 days) or development of increased
intracranial pressure (median 3.5 days). Factors
associated with deterioration were thicker SDH,
greater midline shift, location at the cerebral convexity, history of falls, and alcohol abuse.

SUMMARY
Published literature and widespread clinical experience make it clear that most ASDHs can be
managed nonoperatively. This is especially true
for smaller lesions in patients with good neurologic
status. Even in patients who present with severe
neurologic deficits or coma, the benefit of evacuating small ASDHs is often unclear. These ASDHs
usually resolve spontaneously.
Large ASDHs may require a different approach.
When a comatose patient is found to have a large
ASDH associated with compression of the basal
cisterns, significant midline shift, or other signs of

mass effect, immediate surgery is the default management plan.
More problematic is the management of large
ASDHs in patients with no or minimal symptoms.
Conservative management may be considered in
patients in good neurologic status and, despite
the size of the ASDH, relatively little underlying
mass effect.
The effect of anticoagulant and antiplatelet
medications on the natural history of ASDH is not
clear from the literature. Prudence would suggest
that reversal of such agents be considered in all
patients with ASDH. Likewise, a lower threshold
for early repeat CT scanning may be appropriate
in patients with ASDH who are taking such
medications.
Even if nonoperative management is successful
in the acute phase, the risk remains for subsequent progression of an ASDH into a CSDH that
is large enough to require surgery. Again, the literature is unclear on the effects of anticoagulants or
antihypertensives on such a progression. Scheduled CT scanning 1 to 2 weeks after development
of an ASDH may detect this process before clinical
symptoms appear.
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